Publications
Export 57 results:
Filters: Keyword is Nerve Tissue Proteins [Clear All Filters]
, “Dopaminergic neurons establish a distinctive axonal arbor with a majority of non-synaptic terminals.”, FASEB J, vol. 35, no. 8, p. e21791, 2021.
, “Cell-type-specific role for nucleus accumbens neuroligin-2 in depression and stress susceptibility.”, Proc Natl Acad Sci U S A, vol. 115, no. 5, pp. 1111-1116, 2018.
, “Locally coordinated synaptic plasticity of visual cortex neurons in vivo.”, Science, vol. 360, no. 6395, pp. 1349-1354, 2018.
, “Survival of a Novel Subset of Midbrain Dopaminergic Neurons Projecting to the Lateral Septum Is Dependent on NeuroD Proteins.”, J Neurosci, vol. 37, no. 9, pp. 2305-2316, 2017.
, “Normal Molecular Specification and Neurodegenerative Disease-Like Death of Spinal Neurons Lacking the SNARE-Associated Synaptic Protein Munc18-1.”, J Neurosci, vol. 36, no. 2, pp. 561-76, 2016.
, “Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology.”, Ann Neurol, vol. 78, no. 2, pp. 160-77, 2015.
, “Mutant huntingtin is present in neuronal grafts in Huntington disease patients.”, Ann Neurol, vol. 76, no. 1, pp. 31-42, 2014.
, “Roundabout 1 exists predominantly as a basal dimeric complex and this is unaffected by binding of the ligand Slit2.”, Biochem J, vol. 461, no. 1, pp. 61-73, 2014.
, “Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog. [corrected].”, Cell Stem Cell, vol. 12, no. 4, pp. 426-39, 2013.
, “Peripherin is a subunit of peripheral nerve neurofilaments: implications for differential vulnerability of CNS and peripheral nervous system axons.”, J Neurosci, vol. 32, no. 25, pp. 8501-8, 2012.
, “Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration.”, J Biol Chem, vol. 287, no. 39, pp. 32298-306, 2012.
, “Lmx1a and lmx1b function cooperatively to regulate proliferation, specification, and differentiation of midbrain dopaminergic progenitors.”, J Neurosci, vol. 31, no. 35, pp. 12413-25, 2011.
, “Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.”, Brain, vol. 134, no. Pt 9, pp. 2610-26, 2011.
, “Regulation of Nav1.6 and Nav1.8 peripheral nerve Na+ channels by auxiliary β-subunits.”, J Neurophysiol, vol. 106, no. 2, pp. 608-19, 2011.
, “Distinct biochemical signatures characterize peripherin isoform expression in both traumatic neuronal injury and motor neuron disease.”, J Neurochem, vol. 114, no. 4, pp. 1177-92, 2010.
, “Type III intermediate filament peripherin inhibits neuritogenesis in type II spiral ganglion neurons in vitro.”, Neurosci Lett, vol. 478, no. 2, pp. 51-5, 2010.
, “Real-time imaging reveals defects of fast axonal transport induced by disorganization of intermediate filaments.”, FASEB J, vol. 23, no. 9, pp. 3213-25, 2009.
, “Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish.”, Hum Mol Genet, vol. 17, no. 17, pp. 2691-702, 2008.
, “Differential RNA expression between schizophrenic patients and controls of the dystrobrevin binding protein 1 and neuregulin 1 genes in immortalized lymphocytes.”, Schizophr Res, vol. 100, no. 1-3, pp. 281-90, 2008.
, “[Dysfunction of axonal transport in neuropathies and motor neuron diseases].”, Med Sci (Paris), vol. 24, no. 1, pp. 65-71, 2008.
, “The type III neurofilament peripherin is expressed in the tuberomammillary neurons of the mouse.”, BMC Neurosci, vol. 9, p. 26, 2008.
, “Neuronal expression of peripherin, a type III intermediate filament protein, in the mouse hindbrain.”, Histochem Cell Biol, vol. 128, no. 6, pp. 541-50, 2007.
, “Chemical characterization of newly generated neurons in the striatum of adult primates.”, Exp Brain Res, vol. 170, no. 4, pp. 501-12, 2006.
, “Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin.”, J Neurochem, vol. 98, no. 3, pp. 926-38, 2006.
, “Cytoskeletal defects in amyotrophic lateral sclerosis (motor neuron disease).”, Novartis Found Symp, vol. 264, pp. 183-92; discussion 192-6, 227-30, 2005.
